尼莫地平治疗脑出血后缺血性脑损伤46例疗效观察

Nimodipine for Treating Cerebral Ischemic Injury After Intracerebral Hemorrhage in 46 Cases

目的探讨尼莫地平治疗脑出血后缺血性脑损伤的疗效。方法选择医院收治的脑出血后缺血性脑损伤患者92例,随机均分为研究组和对照组。对照组给予静脉滴注依达拉奉治疗,研究组口服尼莫地平治疗。结果治疗后,研究组患者的Barthel指数评定量表(BI)评分明显高于对照组,神经功能缺损评分(NIHSS)明显低于对照组(P<0.05);研究组患者的总有效率明显高于对照组(P<0.05)。结论尼莫地平治疗脑出血后缺血性脑损伤,明显改善神经缺损,显著提高治疗效果,值得临床推广。

Objective To investigate the clinical effect of nimodipine in the treatment of ischemic brain injury after intracerebral hemorrhage. Methods Totally 92 patients with ischemic brain injury after intracerebral hemorrhage admitted to our hospital were randomly divided into the study group and the control group, 46 cases in each group. The control group was treated with edaravone, while the study group was treated with nimodipine. Results After treatment, the BI score in the study group was significantly higher than that in the control group, but the NIHSS score in the study group was significantly lower than that in the control group （ P 〈 0. 05 ） . The total effective rate in the study group was significantly higher than that in the control group （ P 〈 0. 05 ） . Conclusion Nimodipine in the treatment of ischemic brain injury after cerebral hemorrhage can significantly improve the neurological deficit of the patients, improve the curative effect, it is worthy of clinical promtion.